Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Furin

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|September 15, 2018
Reducing harm in the treatment of multidrug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Global Health|August 19, 2024
The potential distraction of a pan-regimen approach to tuberculosisOxana Rucsineanu, Jennifer Furin
Expert Review of Respiratory Medicine|March 21, 2017
Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosisSylvie Jonckheree, Jennifer Furin
The Lancet. HIV|December 14, 2016
Life in the time of antiretrovirals in South AfricaJennifer Furin, Petros Isaakidis
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 13, 2012
Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?Greg Jonsson, Jennifer Furin
The European Respiratory Journal|April 20, 2019
Protecting those who serve: are we doing enough to prevent tuberculosis in healthcare workers?Jennifer Furin, Giovanni Sotgiu
The Lancet. HIV|March 26, 2022
Helping hospitals heal people with HIV and tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|November 17, 2022
A step in the right direction for children with tuberculosisChloe Maugans, Jennifer Furin
Pathogens (Basel, Switzerland)|May 27, 2023
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant TuberculosisAnja Reuter, Jennifer Furin
Lung India : Official Organ of Indian Chest Society|November 8, 2021
India should speed up access to bedaquiline-based all-oral regimens, not procrastinate furtherZarir F Udwadia, Jennifer Furin
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|September 15, 2018
Reducing harm in the treatment of multidrug-resistant tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Global Health|August 19, 2024
The potential distraction of a pan-regimen approach to tuberculosisOxana Rucsineanu, Jennifer Furin
Expert Review of Respiratory Medicine|March 21, 2017
Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosisSylvie Jonckheree, Jennifer Furin
The Lancet. HIV|December 14, 2016
Life in the time of antiretrovirals in South AfricaJennifer Furin, Petros Isaakidis
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 13, 2012
Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?Greg Jonsson, Jennifer Furin
The European Respiratory Journal|April 20, 2019
Protecting those who serve: are we doing enough to prevent tuberculosis in healthcare workers?Jennifer Furin, Giovanni Sotgiu
The Lancet. HIV|March 26, 2022
Helping hospitals heal people with HIV and tuberculosisAnja Reuter, Jennifer Furin
The Lancet. Infectious Diseases|November 17, 2022
A step in the right direction for children with tuberculosisChloe Maugans, Jennifer Furin
Pathogens (Basel, Switzerland)|May 27, 2023
Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant TuberculosisAnja Reuter, Jennifer Furin
Lung India : Official Organ of Indian Chest Society|November 8, 2021
India should speed up access to bedaquiline-based all-oral regimens, not procrastinate furtherZarir F Udwadia, Jennifer Furin
Pageof 16